Stay updated on CC-220 in Multiple Myeloma Clinical Trial
Sign up to get notified when there's something new on the CC-220 in Multiple Myeloma Clinical Trial page.

Latest updates to the CC-220 in Multiple Myeloma Clinical Trial page
- Check7 days agoChange DetectedChanged the study title wording from 'Dose, Safety, Tolerability, Drug Levels, and Efficacy' to 'Dose, Safety, Tolerability and Efficacy'. Updated the status from 'Results Submitted' to 'Results Posted' and added new sections such as More Information, Limitations and Caveats, Adverse Events, Outcome Measures (Results), Baseline Characteristics, Participant Flow, and References in the 2026 version.SummaryDifference0.9%

- Check14 days agoChange DetectedRecord History now includes Revision: v3.5.0 and removes Revision: v3.4.3.SummaryDifference0.0%

- Check22 days agoChange DetectedThe revision history now includes Revision: v3.4.3 as the latest entry. Revision: v3.4.2 has been removed.SummaryDifference0.0%

- Check29 days agoChange DetectedEight new Results Submission Events were added and seven were removed in the history view, updating the list of events shown under Results Submission.SummaryDifference0.0%

- Check50 days agoChange DetectedAdded Revision: v3.4.2. Removed the prior Notice about lapse in government funding and operating status (including Revision: v3.4.1).SummaryDifference0.3%

- Check57 days agoChange DetectedThe history now includes a new revision v3.4.1 with 7 Results Submission Events, replacing the previous v3.4.0 with 6 events. A government funding lapse notice has been added to the top of the page.SummaryDifference0.4%

Stay in the know with updates to CC-220 in Multiple Myeloma Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CC-220 in Multiple Myeloma Clinical Trial page.